FRANCISCO PARTNERS IV, L.P.
SEC Form 4 insider trading activity
FRANCISCO PARTNERS IV, L.P. has filed 2 SEC Form 4 filings (18 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 27, 2026.
On the most recent filing, FRANCISCO PARTNERS IV, L.P. is listed as 10% Owner at GoodRx Holdings, Inc. Inside the rolling window, FRANCISCO PARTNERS IV, L.P. reported no open-market purchases and 6 open-market sales totaling $9.7M in GDRX. The largest disclosed transaction in the window is a sale of 1,296,177 GDRX shares on Aug 26, 2026, worth $4.5M.
Companies traded
Other insiders at GDRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has FRANCISCO PARTNERS IV, L.P. made?
FRANCISCO PARTNERS IV, L.P. has filed 2 SEC Form 4 filings (18 transaction rows) across 1 company since 2026.
Which companies does FRANCISCO PARTNERS IV, L.P. trade?
FRANCISCO PARTNERS IV, L.P. has filed SEC Form 4 disclosures for 1 company, including GDRX.
When was FRANCISCO PARTNERS IV, L.P.'s most recent SEC Form 4 filing?
FRANCISCO PARTNERS IV, L.P.'s most recent SEC Form 4 filing on Tracefour is dated Aug 27, 2026.
What is FRANCISCO PARTNERS IV, L.P.'s total buy and sell value in the current window?
Inside the rolling retention window, FRANCISCO PARTNERS IV, L.P. bought $0 and sold $9.7M based on SEC Form 4 filings.
What was FRANCISCO PARTNERS IV, L.P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,296,177 GDRX shares on 2026-08-26, worth $4.5M, per SEC Form 4 filings.